REBECCA DIETTERICH: Open Payments
NPI 1689457517 · STROUDSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 76 payments from 12 companies in 2025. Trend: 2023 $521 · 2024 $1,401 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $262 |
| Alkermes, Inc. | 14 | $253 |
| Neurocrine BioSciences, Inc. | 11 | $173 |
| E.R. Squibb & Sons, L.L.C. | 12 | $173 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
Products named: VRAYLAR, ARISTADA, INGREZZA, COBENFY, SPRAVATO, FANAPT, Auvelity, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
